Mayo Clinic Laboratory and Pathology Research Roundup: Feb. 12 - Insights
This week’s Research Roundup highlights the prediction of oncologic outcomes in Renal cell carcinoma after surgery.
Overcoming Fear of Public Speaking with "The Art of Laughter" - Insights
Nhien Chau, Clinical Laboratory Technologist in the Biochemical Genetics Laboratory at Mayo Clinic, decided to face his fear of public speaking by joining the Rochester Chamber Toastmasters group.
Sparrow Health System has chosen Mayo Medical Laboratories as its primary reference laboratory for advanced laboratory testing, enhancing the availability of complex tests and making test results available more quickly to providers and...
Mayo Medical Laboratories and National University Hospital (NUH) in Singapore are now electronically linked via the widely used and secure Health Level 7 interface, enabling NUH to order specialized Mayo laboratory tests and receive patient...
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
Newborn Screening at Mayo Clinic Laboratories
Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.
Thrombotic Microangiopathies (TMA) [Test in Focus] - Insights
Meera Sridharan, M.D., Ph.D., explains Mayo Clinic Labs’ testing approach for atypical hemolytic uremic syndrome (aHUS). The serological complement panel examines nine analytes to gain a thorough understanding of the complement cascade to...
Matthew J. Schultz, Ph.D., and Amy L. White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related...
Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S., explain how Mayo Clinic Laboratories' enhanced MayoComplete Solid Tumor Panel better profiles tumor genetics. Defining tumor pathogenesis can guide targeted...
Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights
By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...